what is elife?
DESCRIPTION
What is eLife?. A collaboration between funders and the research community to improve research communication A researcher-led digital publication for outstanding work across the life sciences - PowerPoint PPT PresentationTRANSCRIPT
v11
v11
What is eLife?• A collaboration between funders and the research
community to improve research communication• A researcher-led digital publication for outstanding
work across the life sciences• A platform to maximize the reach and influence of
new research and to showcase new approaches for the presentation and assessment of research
v11
eLife – scope• From the most basic and theoretical work through to
translational, applied and clinical research. • Highly influential work that advances understanding,
opens new doors or has real-world impacts.
v11
eLife – goals1. To make publishing more efficient, providing
outstanding service through a swift, decisive and fair editorial process.
2. To exploit digital media in the presentation of research, increasing its utility for further research and broadening participation to the widest possible audience.
3. To drive open access by providing an outstanding new publishing option for ground-breaking research.
4. To catalyze change in research communication.
v11
How will eLife work?
v11
World-class backing
• Supported by three of the world’s leading research funders
• Effective research communication is a critical part of research
• Editorially, eLife is entirely independent of the funders
v11
Edited by researchers
Stylianos Antonarakis, University of Geneva Medical School (Switzerland)
Ian Baldwin, Max Planck Institute for Chemical Ecology (Germany)
Catherine Dulac, Harvard University (USA)Joe Goldstein, University of Texas Southwestern
Medical Center (USA)Tony Hunter, Salk Institute (USA)Prabhat Jha, University of Toronto (Canada)John Kuriyan, University of California at
Berkeley (USA)Richard Losick, Harvard University (USA)James Manley, Columbia University (USA)Eve Marder, Brandeis University (USA)
Michael Marletta, The Scripps Research Institute (USA)
Chris Ponting, University of Oxford (UK)Janet Rossant, University of Toronto (Canada)Charles Sawyers, Memorial Sloan Kettering
Cancer Center (USA)Tadatsugu Taniguchi, University of Tokyo
(Japan)K. VijayRaghavan, National Center for
Biological Sciences (India)Xiaodong Wang, National Institute of Biological
Sciences (China)Huda Zoghbi, Baylor College of Medicine (USA)
Editor-in-Chief - Randy Schekman, University of California at Berkeley (USA)Deputy Editor – Fiona Watt, King’s College London (UK)Deputy Editor – Detlef Weigel, Max Planck Institute for Developmental Biology (Germany)Senior Editors
A 175-member Board of Reviewing Editors
A new approach to the editorial process
v11
Cover letter and single
Swift triage process by
Senior Editors
Full submission
BRE member
plus external
reviewer(s)
Decision after peer
review
Revision assessed by
BRE member
Limit submissions entering peer review
Consultation amongst reviewers before decision
Single set of instructions – focused revision
Limit rounds of revision
Streamlined submission process prior to triage
Authors upload source files, including rich media and source data files where relevant
The end result> A constructive process> Reduced times from submission to acceptance
v11
• Interim findings may be published provided the conclusion is clear and the finding novel and of high importance
• International Board of Reviewing Editors includes outstanding junior and experienced investigators
• Fast turn-around for time-sensitive work• New and exciting findings will be published even if
another paper comes out during revision
Selective but not exclusive
v11
Born digital• No limits to article number• No (unnecessary) limits to article length• Use of rich media encouraged• Inclusion of underlying data• Supplementary information reserved for data/datasets• Added-value content to extend the reach of the work• Metrics and indicators of influence for all articles
v11
Born free• Results will be available for free immediately on
publication• Readers will have the right to use content without
restriction, providing full author attribution (Creative Commons-Attribution license)
• All content will also be deposited in PubMed Central
Initially - also free of publication fees
v11
eLife’s charter for authors• We commit to serving the interests of early-career
researchers.• We commit to delivering an outstanding editorial service
that is constructive, fair, swift, and decisive. • We commit to maximizing the influence of every author’s
work, through effective promotion, open access, and adding value.
• We commit to demonstrating the significance of each article through dynamic metrics and indicators of influence.
eLife will help advance careers
Join usRandy [email protected]
v11